WO2010090491A3 - Novel salts of adefovir dipivoxil and preparation method thereof - Google Patents
Novel salts of adefovir dipivoxil and preparation method thereof Download PDFInfo
- Publication number
- WO2010090491A3 WO2010090491A3 PCT/KR2010/000771 KR2010000771W WO2010090491A3 WO 2010090491 A3 WO2010090491 A3 WO 2010090491A3 KR 2010000771 W KR2010000771 W KR 2010000771W WO 2010090491 A3 WO2010090491 A3 WO 2010090491A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- adefovir dipivoxil
- preparation
- salts
- novel salts
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Abstract
The present invention relates to novel salts of Adefovir dipivoxil and a preparation method thereof. More specifically, the present invention relates to high-quality crystalline acid addition salts and a preparation method thereof, wherein the crystalline acid addition salts have improved solubility, non-hygroscopicity, bioavailability, and powder flowability by reacting Adefovir dipivoxil with pharmaceutically acceptable fatty acids. The novel salts of Adefovir dipivoxil prepared according to the invention are physicochemically and pharmaceutically stable and show improved properties over existing Adefovir dipivoxil or salts thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2009-0010190 | 2009-02-09 | ||
KR20090010190 | 2009-02-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010090491A2 WO2010090491A2 (en) | 2010-08-12 |
WO2010090491A3 true WO2010090491A3 (en) | 2011-01-27 |
Family
ID=42542535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/000771 WO2010090491A2 (en) | 2009-02-09 | 2010-02-09 | Novel salts of adefovir dipivoxil and preparation method thereof |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20100091127A (en) |
WO (1) | WO2010090491A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20120586A1 (en) | 2012-04-11 | 2013-10-12 | Milano Politecnico | CO-CRYSTALS OF 3-IODIOPROPINYL BUTYCARBAMMATE |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020045599A1 (en) * | 1997-07-25 | 2002-04-18 | Gilead Sciences, Inc. | Nucleotide analog compositions |
WO2004078163A2 (en) * | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
US7417036B2 (en) * | 2002-11-12 | 2008-08-26 | Tianjin Kinsly Pharmaceutical Co. Ltd. | Crystal form of adefovir dipivoxil and its preparation |
-
2010
- 2010-02-08 KR KR1020100011601A patent/KR20100091127A/en not_active Application Discontinuation
- 2010-02-09 WO PCT/KR2010/000771 patent/WO2010090491A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020045599A1 (en) * | 1997-07-25 | 2002-04-18 | Gilead Sciences, Inc. | Nucleotide analog compositions |
US7417036B2 (en) * | 2002-11-12 | 2008-08-26 | Tianjin Kinsly Pharmaceutical Co. Ltd. | Crystal form of adefovir dipivoxil and its preparation |
WO2004078163A2 (en) * | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
Non-Patent Citations (1)
Title |
---|
LUNG-CHI YUAN ET AL.: "Effect of Carbonate Salts on the Kinetics of Acid-Catalyzed Dimerization of Adefovir Dipivoxil.", PHARMACEUTICAL RESEARCH., vol. 17, no. 9, September 2000 (2000-09-01), pages 1098 - 1103 * |
Also Published As
Publication number | Publication date |
---|---|
KR20100091127A (en) | 2010-08-18 |
WO2010090491A2 (en) | 2010-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008007392A3 (en) | Process for the preparation of tenofovir | |
NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
AU2015221439B2 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same | |
WO2008022777A8 (en) | Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives | |
WO2011039108A3 (en) | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives | |
WO2010139981A3 (en) | Processes for preparing crystalline forms of dasatinib | |
IN2014CN03482A (en) | ||
BRPI0817747A8 (en) | PROCESS FOR THE PREPARATION OF 2-DI-HALOGENOACYL-3-AMINO-ACRYLIC ACID DERIVATIVES | |
WO2011015287A3 (en) | Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
WO2009118754A3 (en) | A process for preparing a stable lyophilized composition | |
WO2010100429A8 (en) | Process for the preparation of cinacalcet and salts thereof, and intermediates for use in the process | |
WO2010070677A3 (en) | A process for the preparation of prasugrel and its pharmaceutically acceptable salts thereof | |
MX2011009898A (en) | Process for the preparation of propionic acid derivatives. | |
WO2008117305A3 (en) | A novel process for preparing pregabalin and its acid addition salts | |
WO2012038979A3 (en) | A process for preparation of ertapenem | |
WO2012112841A3 (en) | [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation | |
WO2009037538A3 (en) | Process for the preparation of lamivudine form i | |
WO2011102640A3 (en) | Method for preparing sitagliptin and amine salt intermediates used therein | |
WO2010150144A3 (en) | Low dose pharmaceutical compositions of celecoxib | |
IN2014MN00971A (en) | ||
WO2012026897A9 (en) | A process for the preparation of imatinib base | |
WO2010110622A3 (en) | Novel crystal forms of adefovir dipivoxil and processes for preparing the same | |
WO2010090491A3 (en) | Novel salts of adefovir dipivoxil and preparation method thereof | |
WO2009021943A3 (en) | Novel preparation process | |
WO2009122429A3 (en) | Crystalline oxybutynin and process for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10738775 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10738775 Country of ref document: EP Kind code of ref document: A2 |